Business

Australia sues Microsoft over AI-linked subscription price hikes

Australia sues Microsoft over AI-linked subscription price hikes

(Reuters) -Australia's competition regulator on Monday sued Microsoft, accusing it of misleading customers into paying higher prices for Microsoft 365…

October 27, 2025

Japan's leading indicator of service inflation perks up in September

TOKYO (Reuters) -A leading indicator of Japan's service-sector inflation perked up for the second straight month in September, data showed…

October 27, 2025

Trump reverses Biden-era rules on copper smelters

By Jarrett Renshaw and Ernest Scheyder WASHINGTON (Reuters) -U.S. President Donald Trump on Friday reversed a Biden-era air pollution rule…

October 27, 2025

Workers reject Boeing's latest offer after nearly three months on strike

By Dan Catchpole (Reuters) -Striking workers at Boeing Defense in the St. Louis area rejected the company's latest contract proposal…

October 27, 2025

Novartis to acquire Avidity Biosciences for about $12 billion

(Fixes timeframe in last paragraph to "In July") By Padmanabhan Ananthan and Angela Christy M (Reuters) -Swiss drugmaker Novartis on…

October 27, 2025

Workers reject Boeing's latest offer after nearly three months on strike

By Dan Catchpole (Reuters) -Striking workers at Boeing Defense in the St. Louis area rejected the company's latest contract proposal…

October 27, 2025

Novartis to acquire Avidity Biosciences for $12 billion

(Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire Avidity Biosciences for $12 billion. (Reporting by Angela Christy…

October 27, 2025

Novartis to acquire Avidity Biosciences for about $12 billion

By Padmanabhan Ananthan and Angela Christy M (Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech…

October 27, 2025

Novartis to acquire Avidity Biosciences for $12 billion

(Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire Avidity Biosciences for $12 billion. (Reporting by Angela Christy…

October 27, 2025

Novartis to acquire Avidity Biosciences for $12 billion

(Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire Avidity Biosciences for $12 billion. (Reporting by Angela Christy…

October 27, 2025